Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 9:49 PM

    Rubius Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -179.67M -196.55M
    Depreciation & Amortization
    		 6.25M 7.72M
    Stock-Based Compensation
    		 15.78M 35.61M
    Other Working Capital
    		 -7.71M 836K
    Other Non-Cash Items
    		 25.01M 1.28M
    Deferred Income Tax
    		 n/a 118K
    Change in Working Capital
    		 -17.52M 6.69M
    Operating Cash Flow
    		 -150.14M -145.12M
    Capital Expenditures
    		 -5.3M -3.65M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 -83.63M n/a
    Sales Maturities Of Investments
    		 83.93M 85M
    Other Investing Acitivies
    		 17.94M n/a
    Investing Cash Flow
    		 12.94M 81.35M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 -75.47M 198.45M
    Financial Cash Flow
    		 -75.47M 198.45M
    Net Cash Flow
    		 -212.67M 134.68M
    Free Cash Flow
    		 -155.45M -148.77M

    Add to Watchlist